
GC62236
SSAA09E2
Also known as N-[[4-(4-methylpiperazin-1-yl)phenyl]methyl]-1,2-oxazole-5-carboxamide
SSAA09E2 is an inhibitor of SARS-CoV (Severe acute respiratory syndrome-Coronavirus) replication, acting by blocking early interactions of SARS-S with the receptor for SARS-CoV, Angiotensin Converting Enzyme-2 (ACE2)
ChemicalCAS883944-52-3MW300.36FormulaC16H20N4O2
- CAS number
- 883944-52-3
- Molecular weight
- 300.36
- Formula
- C16H20N4O2
- Solubility
- DMSO : 250 mg/mL (832·33 mM; Need ultrasonic)
- InChIKey
- OMRXBNSVRJWWAZ-UHFFFAOYSA-N
- Catalogue number
- GC62236
- Brand
- GLPBIO
Computed properties PubChem CID 2738575 · XLogP 1.4 · TPSA 61.6 Ų · H-bond donors 1
- XLogP
- 1.4
- TPSA
- 61.6 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 4
- Heavy atoms
- 22
SMILES CN1CCN(CC1)C2=CC=C(C=C2)CNC(=O)C3=CC=NO3
Computed descriptors from PubChem (CID 2738575), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il